Previous 10 | Next 10 |
Net Product Sales Increase 40% Year-Over-Year, Non-GAAP Adjusted EBITDA Increases to $22.9 million Raises Full Year Revenue and Non-GAAP Adjusted EBITDA Guidance LAKE FOREST, Ill., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” ...
Assertio Therapeutics ( NASDAQ: ASRT ) is scheduled to announce Q2 earnings results on Monday, August 8th, before market open. The consensus EPS Estimate is $0.10 (+131.3% Y/Y) and the consensus Revenue Estimate is $31.78M (+25.3% Y/Y). Over the last 2 years, ASRT ha...
ANIP , APRN , ASRT , BNTX , CLVS , D , DCTH , DTIL , ELAN , ENR , FREY , GOLD , HE , HEP , ITUB , KNDI , KOS , LINC , OTCPK:LKNCY , OSG , PDSB , PLTR , PRTY , RDWR , RETA , SOHU , TGN...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips In recent weeks, the stock market has stabilized after June’s sell-off, but it may take time before bullishness makes a comeback. Plenty of uncertainty remains, including further interest rate hikes , continued high...
Are you looking for some hot penny stocks to buy this week? You’re not alone ,and believe it or not, the recent volatility in the stock market has brought about a risk-on approach to cspecificgroups of stocks & industries in the market. Cheap stocks under $5 are one of these grou...
LAKE FOREST, Ill., July 25, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it will release second quarter 2022 fi...
LAKE FOREST, Ill., July 12, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to patients, announced that effective July 1, 2022, the Compensation Com...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Given the stock market’s performance lately, adding penny stocks to buy (i.e. stocks trading for under $5 per share) to your portfolio may at first glance sound like not the right move. However, today’s market...
In a note 12 months ago I told the story of how Assertio, formerly DepoMed, nearly went under after its disastrous acquisition of opioid drug Nucynta. A new management team was able to dispose of the asset, settle debts, and acquire a portfolio of NSAIDs, which have driven exceptional...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Finding stocks with a moonshot potential is like finding gold — you must know where to search, what criteria to use in a stock screener and how to make a narrow list of selections from that info. Even the best penny ...
News, Short Squeeze, Breakout and More Instantly...
Assertio Therapeutics Inc. Company Name:
ASRT Stock Symbol:
NASDAQ Market:
Assertio Therapeutics Inc. Website:
LAKE FOREST, Ill., July 24, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that it will rel...
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ASRT on July 3, 2024 06:04AM ET. ASRT was trading at $1.15 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief...